Pharmaceutical News and Articles

USDA Orders Testing of Milk Supply for Presence of Bird Flu Virus

must hand over samples for testing to USDA staff upon request. According to the USDA, this could be an efficient way to identify herds infected with H5N1.As of

New Therapy Helps Patients With Tough-to-Treat Bladder Cancers

There s new hope for people battling advanced bladder cancer who do not respond to first-line therapy, researchers report. An experimental new drug with the unw

AI Reads Multiple Mammograms to Help Predict Breast Cancer Risk

A new AI can help identify women at higher risk for developing breast cancer by tracking changes in breast tissue, a new study shows. The AI compares women s ow

1 in 20 Pregnant U.S. Women Face Emotional, Physical Abuse

Pregnancy can be a trying time for women at best, but new research shows that 1 in every 20 pregnant American women also suffer physical, sexual or emotional ab

Analysis Predicts Big Drop for U.S. in Global Health Rankings

Americans are falling farther behind the rest of the developed world when it comes to health and life expectancy, a new study shows. Life expectancy in the Unit

Insurer Anthem Rescinds Anesthesia Policy Change After Backlash

After facing weeks of pushback, health insurer Anthem Blue Cross Blue Shield said Thursday it will not go ahead with a policy change that would have limited rei

Phanes Therapeutics’ PT217 Granted Fast Track Designation by the FDA for NEPC

SAN DIEGO, Dec. 4, 2024 PRNewswire Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in

Cytokinetics Announces FDA Acceptance of New Drug Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy

Prevention Outpaced Treatment Advances in Saving Lives From Major Cancers

An ounce of prevention is worth a pound of cure, founding father Benjamin Franklin once said. That s definitely true of cancer, a new study has found. Cancer pr

Weight Loss Brings Americans Big Health Care Savings

The advent of GLP-1 weight-loss medications such as Wegovy and Zepbound has spurred debate as to whether the drugs cost should be covered by Medicare, Medicaid